243 related articles for article (PubMed ID: 15304178)
41. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
43. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.
Nordin C; Kohli A; Beca S; Zaharia V; Grant T; Leider J; Marantz P
J Electrocardiol; 2006 Apr; 39(2):199-205. PubMed ID: 16580420
[TBL] [Abstract][Full Text] [Related]
44. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.
Nobre V; Guedes AC; Martins ML; Barbosa-Stancioli EF; Serufo JC; Proietti FA; Ribas JG; Ferreira CE; Lambertucci JR;
Clin Infect Dis; 2006 Nov; 43(10):1257-63. PubMed ID: 17051489
[TBL] [Abstract][Full Text] [Related]
45. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
46. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
47. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
49. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
[TBL] [Abstract][Full Text] [Related]
50. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil.
Le Marchand C; Bahia F; Page K; Brites C
Braz J Infect Dis; 2015; 19(5):486-91. PubMed ID: 26254690
[TBL] [Abstract][Full Text] [Related]
52. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
53. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
Collazos J; Cartón JA; Asensi V
HIV Med; 2011 May; 12(5):308-15. PubMed ID: 20946441
[TBL] [Abstract][Full Text] [Related]
55. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
[TBL] [Abstract][Full Text] [Related]
56. The association of infection and clinical severity in sickle cell anaemia patients.
Neto JP; Lyra IM; Reis MG; Goncalves MS
Trans R Soc Trop Med Hyg; 2011 Mar; 105(3):121-6. PubMed ID: 21216418
[TBL] [Abstract][Full Text] [Related]
57. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
Vallejo A; Loza E; Mateos ML
J Clin Virol; 2015 Mar; 64():72-3. PubMed ID: 25728082
[No Abstract] [Full Text] [Related]
58. HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital.
Quiros-Roldan E; Moretti F; Torti C; Casari S; Castelli F; Beltrame A; Carosi G
Infection; 2003 Jun; 31(3):172-3. PubMed ID: 12789475
[TBL] [Abstract][Full Text] [Related]
59. HIV/HTLV-I coinfection and clinical grade at diagnosis.
Chavance M; Neisson-Vernant C; Quist D; Monplaisir N; Armengaud B; Chout R
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):91-5. PubMed ID: 8548352
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1.
Moreira M; Ramos A; Netto EM; Brites C
Braz J Infect Dis; 2013; 17(6):661-6. PubMed ID: 24029434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
